1. Home
  2. RGEN vs EHC Comparison

RGEN vs EHC Comparison

Compare RGEN & EHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Repligen Corporation

RGEN

Repligen Corporation

N/A

Current Price

$179.65

Market Cap

10.0B

Sector

Health Care

ML Signal

N/A

Logo Encompass Health Corporation

EHC

Encompass Health Corporation

N/A

Current Price

$119.64

Market Cap

11.2B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
RGEN
EHC
Founded
1981
1983
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Hospital/Nursing Management
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
10.0B
11.2B
IPO Year
1995
1994

Fundamental Metrics

Financial Performance
Metric
RGEN
EHC
Price
$179.65
$119.64
Analyst Decision
Buy
Strong Buy
Analyst Count
22
13
Target Price
★ $189.70
$148.17
AVG Volume (30 Days)
★ 880.1K
680.7K
Earning Date
10-27-2026
10-28-2026
Dividend Yield
N/A
★ 0.69%
EPS Growth
★ 286.96
24.22
EPS
0.24
★ 3.47
Revenue
★ $141,236,000.00
N/A
Revenue This Year
$12.04
$8.84
Revenue Next Year
$17.80
$8.26
P/E Ratio
$805.46
★ $35.45
Revenue Growth
★ 35.10
N/A
52 Week Low
$100.99
$92.77
52 Week High
$198.87
$127.99

Technical Indicators

Market Signals
Indicator
RGEN
EHC
Relative Strength Index (RSI) 63.35 52.70
Support Level $159.22 $119.08
Resistance Level N/A $127.50
Average True Range (ATR) 6.58 2.79
MACD 0.98 -0.21
Stochastic Oscillator 75.63 50.52

Price Performance

Historical Comparison
RGEN
EHC

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, and other life science companies. It sells four main product categories: filtration and fluid management is the largest category (about 55% of total revenue), while chromatography, proteins, and process analytics are 21%, 11%, and 13%, respectively. Customers in North America, Europe, and Asia-Pacific contribute about 44%, 37%, and 19% of revenue, respectively.

About EHC Encompass Health Corporation

Encompass Health Corp provides post-acute healthcare services in the United States through a network of inpatient rehabilitation hospitals, which is the company's sole segment. Inpatient rehabilitation contributes the majority of the firm's revenue and provides specialized rehabilitative treatment through a network of inpatient hospitals. The company's inpatient rehabilitation hospitals provide a higher level of rehabilitative care to patients who are recovering from conditions such as stroke and other neurological disorders, cardiac and pulmonary conditions, brain and spinal cord injuries, complex orthopedic conditions, and amputations.

Share on Social Networks: